AI Weekly: Corporate AI labs’ turn toward commercial research highlights need for investment in basic science
November 9, 2021
Google’s parent company Alphabet last week launched a subsidiary focused on AI-powered drug discovery called Isomorphic Labs. Helmed by Demis Hassabis, the cofounder of DeepMind, Isomorphic will use AI to identify disease treatments that have thus far eluded researchers, according to a blog post.
“Isomorphic Labs [is] a commercial venture with the mission to reimagine the entire drug discovery…